Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginseng royal jelly chewable tablets are a combination therapeutic product containing extracts of Panax ginseng and royal jelly. Marketed by Hunan Warrant Chiral Pharmaceutical, the product is used as a tonic to enhance physical performance, reduce fatigue, and support the immune system. Ginseng provides adaptogenic effects primarily through its ginsenoside content, which modulates the hypothalamic-pituitary-adrenal (HPA) axis and exhibits antioxidant properties. Royal jelly, a nutrient-dense substance secreted by honeybees, contributes proteins, lipids (such as 10-hydroxy-2-decenoic acid), and vitamins that support metabolic and immunological health. The chewable tablet formulation is designed for ease of oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginseng royal jelly chewable tablets.